Q4 2024 Holdings
Filed 2025-02-12 | 7 holdings | $86.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc.(GLUE) | Common Stock | 61225M102 | $39.2M | 5,652,922 | 45.2% |
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $19.6M | 498,558 | 22.6% |
| Contineum Therapeutics, Inc.(CTNM) | Common Stock | 21217B100 | $13.5M | 918,163 | 15.5% |
| Skye Bioscience, Inc.(SKYE) | Common Stock | 83086J200 | $5.7M | 2,007,704 | 6.5% |
| Repare Therapeutics, Inc.(RPTX) | Common Stock | 760273102 | $3.5M | 2,646,657 | 4.0% |
| Tempest Therapeutics, Inc.(OVASUSD) | Common Stock | 87978U108 | $2.9M | 3,507,055 | 3.4% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $2.4M | 506,821 | 2.7% |